South & Central America Rapid Test Kit Market Forecast to 2030

South & Central America Rapid Test Kit Market Forecast to 2030

South & Central America Rapid Test Kit Market Forecast to 2030 – Regional Analysis – by Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), and End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others)

Send Enquiry
Item ID: BMIRE00030560 Category: Tag:

$2,485 – $3,885

Description

The South & Central America rapid test kit market was valued at US$ 926.12 million in 2022 and is expected to reach US$ 1,295.57 million by 2030; it is estimated to record a CAGR of 4.3% from 2022 to 2030.

Increasing Preference for PCR Techniques Bolster South & Central America Rapid Test Kit Market

In recent years, molecular methods such as PCR have evolved as more effective diagnostic tools, as they aid in the precise diagnosis of a wide range of infectious diseases. Most of the popular molecular tests use reverse transcription polymerase chain reaction (RT-PCR). The technique provides reproducible results that are comparable between different laboratories and hence are accepted worldwide. The manufacturers are involved in new PCR developments.

For instance, GeneSoC is a recently developed system in which the PCR reaction solutions are reciprocally driven over numerous preheated zones and encapsulated on a chip within an extremely thin flow channel. GeneSoC is available for multiplex real-time PCR and is capable of concurrently detecting 3 fluorescence channels. It is regarded as an excellent alternative diagnostic technology for the detection of influenza A and B viruses, as it completes the real-time RT-PCR reaction in ~16 minutes. Further, the application of PCR technologies is also increasing in clinical microbiology, virology, parasitology, biotechnology, and allied fields due to the simple, rapid, and highly specific screening enabled by this tool. Thus, the growing preference for PCR as a diagnostic and clinical tool is expected to provide lucrative opportunities to the rapid test kits market during the forecast period.

South & Central America Rapid Test Kit Market Overview

According to the World Health Organization (WHO), Brazil is among the 20 countries with a high prominence rate of tuberculosis. Brazil accounted for 33% of total cases reported in 2020. In 2021, Brazil recorded 68,271 new TB cases, which corresponds to an incidence rate of 32 cases per 100,000 people. TB incidence is slowly increasing owing to an upward trend in Brazil. In Brazil, the Xpert MTB/RIF assay-a rapid molecular test for tuberculosis (RMT-TB)-is used to diagnose new cases of pulmonary and laryngeal tuberculosis in adults and adolescents.

During the COVID-19 pandemic in Brazil, the country’s Health Ministry issued around a third of the 22.9 million RT-PCR test kits. The federal government provided 6.43 million real-time PCR assays for detecting SARS-CoV-2 in the states. Several players in Brazil are involved in the manufacturing of rapid test kits. Thus, the aforementioned factors are likely to contribute to the rapid test kits market growth.

South & Central America Rapid Test Kit Market Revenue and Forecast to 2030 (US$ Million)

South & Central America Rapid Test Kit Market Segmentation

The South & Central America rapid test kit market is segmented based on type, product, technology, application, end user, and country. Based on type, the South & Central America rapid test kit market is segmented into rapid antigen testing, rapid antibody testing, and others. The rapid antigen testing segment held the largest market share in 2022.

In terms of product, the South & Central America rapid test kit market is bifurcated into over-the-counter rapid testing kit and professional rapid testing kit. The over-the-counter rapid testing kit segment held a larger market share in 2022.

By technology, the South & Central America rapid test kit market is segmented into lateral flow assay, solid phase, agglutination, immunospot assay, and cellular component-based. The lateral flow assay segment held the largest market share in 2022.

Based on application, the South & Central America rapid test kit market is categorized into blood glucose testing, infectious disease testing, pregnancy and fertility, cardiometabolic testing, and others. The blood glucose testing segment held the largest market share in 2022.

In terms of end user, the South & Central America rapid test kit market is segmented into hospital and clinics, home care, diagnostics centers, and others. The hospital and clinics segment held the largest market share in 2022.

Based on country, the South & Central America rapid test kit market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America rapid test kit market share in 2022.

F. Hoffmann-La Roche Ltd, Becton Dickinson and Co, ARKRAY Inc, Fujirebio Europe NV, bioMerieux SA, Cepheid, Meril Life Sciences Pvt Ltd, QIAGEN NV, Guangzhou Wondfo Biotech Co Ltd, Abbott Laboratories, Trinity Biotech Plc, Premier Medical Corp Pvt Ltd, Bio-Rad Laboratories Inc, Hologic Inc, DiaSorin SpA, and Beckman Coulter Inc are some of the leading players operating in the South & Central America rapid test kit market.

Summary Info

Industry:

Pricing options:

, ,

Geographical coverage:

,

Year of Publication:

At 4.3% CAGR, South & Central America Rapid Test Kit Market is Speculated to be Worth US$ 1,295.57 Million by 2030, says the Research Team

According to the Research Team’ research, the South & Central America rapid test kit market was valued at US$ 926.12 million in 2022 and is expected to reach US$ 1,295.57 million by 2030, registering a CAGR of 4.3% from 2022 to 2030. Innovations in rapid antigen tests and increasing preference for PCR techniques are among the critical factors attributed to the South & Central America rapid test kit market expansion.

Operations of multiplex rapid antigen tests are based on multicolored nanoparticles and cross-reactive antibodies, and these test kits can be developed at low costs. When various respiratory pathogens are circulating simultaneously in a host body, rapid multiplex diagnostic testing helps healthcare providers supervise their patients with greater effectiveness. These tests can help avoid misdiagnosis that is possible due to overlapping clinical symptoms. By eliminating diagnostic uncertainty, they help healthcare providers make apt decisions about the commencement and discontinuation of antimicrobial therapies. Compared to single specimen antigen tests kits, multiplex rapid antigen tests kits can detect many respiratory viruses from a single specimen, without compromising on the quality of results. Thus, innovations such as multiplex rapid antigen tests are emerging as future trends in the rapid test kits market.

On the contrary, uncertainties related to accuracy of results hamper the growth of South & Central America rapid test kit market.

Based on type, the South & Central America rapid test kit market is categorized into rapid antigen testing, rapid antibody testing, and others. The rapid antigen testing segment held 63.8% market share in 2022, amassing US$ 591.10 million. It is projected to garner US$ 870.83 million by 2030 to register 5.0% CAGR during 2022-2030.

In terms of product, the South & Central America rapid test kit market is bifurcated into over-the-counter rapid testing kit and professional rapid testing kit. The over-the-counter rapid testing kit segment held 61.9% share of South & Central America rapid test kit market in 2022, amassing US$ 572.98 million. It is projected to garner US$ 826.00 million by 2030 to expand at 4.7% CAGR during 2022-2030.

By technology, the South & Central America rapid test kit market is segmented into lateral flow assay, solid phase, agglutination, immunospot assay, and cellular component-based. The lateral flow assay segment held 44.8% share of South & Central America rapid test kit market in 2022, amassing US$ 415.13 million. It is projected to garner US$ 597.51 million by 2030 to expand at 4.7% CAGR during 2022-2030.

In terms of application, the South & Central America rapid test kit market is categorized into blood glucose testing, infectious disease testing, pregnancy and fertility, cardiometabolic testing, and others. The blood glucose testing segment held 54.9% share of South & Central America rapid test kit market in 2022, amassing US$ 508.56 million. It is projected to garner US$ 733.98 million by 2030 to expand at 4.7% CAGR during 2022-2030.

By end user, the South & Central America rapid test kit market is segmented into hospital and clinics, home care, diagnostics centers, and others. The hospital and clinics segment held 47.2% share of South & Central America rapid test kit market in 2022, amassing US$ 436.78 million. It is projected to garner US$ 609.39 million by 2030 to expand at 4.3% CAGR during 2022-2030.

Based on country, the South & Central America rapid test kit market has been categorized into Brazil, Argentina, and the Rest of South & Central America. Our regional analysis states that Brazil captured 58.7% share of South & Central America rapid test kit market in 2022. It was assessed at US$ 543.38 million in 2022 and is likely to hit US$ 782.77 million by 2030, exhibiting a CAGR of 4.7% during 2022-2030.

Key players operating in the South & Central America rapid test kit market are F. Hoffmann-La Roche Ltd, Becton Dickinson and Co, ARKRAY Inc, Fujirebio Europe NV, bioMerieux SA, Cepheid, Meril Life Sciences Pvt Ltd, QIAGEN NV, Guangzhou Wondfo Biotech Co Ltd, Abbott Laboratories, Trinity Biotech Plc, Premier Medical Corp Pvt Ltd, Bio-Rad Laboratories Inc, Hologic Inc, DiaSorin SpA, and Beckman Coulter Inc, among others.

In November 2023, ARKRAY Inc launched a rapid diagnosis product to check hypothyroidism in dogs. The company has launched Vcheck cTSH, a testing reagent to be used with the Vcheck V200, developed by BioNote, Inc. The newly launched product can measure TSH (thyroid-stimulating hormone) and T4 (thyroid hormone) to diagnose hypothyroidism in dogs.

In October 2022, Roche announced the launch of the Anti-PRAME (EPR 20330) Rabbit Monoclonal Primary Antibody for identifying PRAME protein expression in tissue samples of patients suspected of having melanoma. The newly launched antibody is fully automated on the full line of Roche BenchMark IHC/ISH instruments. It is validated to be used with OptiView DAB IHC Detection, ultraView Universal DAB Detection, and ultraView Universal Alkaline Phosphatase Red Detection Kits.

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America rapid test kit market.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the South & Central America rapid test kit market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the South & Central America rapid test kit market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.
TABLE OF CONTENTS

1. Introduction
1.1 The the Reporting Teams Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Rapid Test Kits Market – Key Industry Dynamics
4.1 Market Drivers
4.1.1 Rising Prevalence of Genetic and Infectious Diseases
4.1.2 Strategic Initiatives by Manufacturers
4.2 Market Restraints
4.2.1 Uncertainties Related to Accuracy of Results
4.3 Market Opportunities
4.3.1 Increasing Preference for PCR Techniques
4.4 Future Trends
4.4.1 Innovations in Rapid Antigen Tests
4.5 Impact Analysis
5. Rapid Test Kits Market – South & Central America Market Analysis
5.1 Rapid Test Kits Market Revenue (US$ Mn), 2020 – 2030
6. South & Central America Rapid Test Kits Market Analysis – by Type
6.1 Overview
6.2 Rapid Antigen Testing
6.2.1 Overview
6.2.2 Rapid Antigen Testing: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
6.3 Rapid Antibody Testing
6.3.1 Overview
6.3.2 Rapid Antibody Testing: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
6.4 Others
6.4.1 Overview
6.4.2 Others: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
7. South & Central America Rapid Test Kits Market Analysis – by Product
7.1 Overview
7.2 Over-the-Counter Rapid Testing Kit
7.2.1 Overview
7.2.2 Over-the-Counter Rapid Testing Kit: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
7.3 Professional Rapid Testing Kit
7.3.1 Overview
7.3.2 Professional Rapid Testing Kit: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
8. South & Central America Rapid Test Kits Market Analysis – by Technology
8.1 Overview
8.2 Lateral Flow Assay
8.2.1 Overview
8.2.2 Lateral Flow Assay: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
8.3 Solid Phase
8.3.1 Overview
8.3.2 Solid Phase: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Agglutination
8.4.1 Overview
8.4.2 Agglutination: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Immunospot Assay
8.5.1 Overview
8.5.2 Immunospot Assay: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Cellular-Component Based
8.6.1 Overview
8.6.2 Cellular-Component Based: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
9. South & Central America Rapid Test Kits Market Analysis – by Application
9.1 Overview
9.2 Blood Glucose Testing
9.2.1 Overview
9.2.2 Blood Glucose Testing: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
9.3 Infectious Disease Testing
9.3.1 Overview
9.3.2 Infectious Disease Testing: Rapid Test Kits Market, by Application – Revenue and Forecast to 2030 (US$ Million)
9.3.3 Infectious Disease Testing: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Cardiometabolic Testing
9.4.1 Overview
9.4.2 Cardiometabolic Testing: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Pregnancy and Fertility
9.5.1 Overview
9.5.2 Pregnancy and Fertility: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
10. South & Central America Rapid Test Kits Market Analysis – by End User
10.1 Overview
10.2 Hospital and Clinics
10.2.1 Overview
10.2.2 Hospital and Clinics: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
10.3 Diagnostic Centers
10.3.1 Overview
10.3.2 Diagnostic Centers: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
10.4 Home-Care
10.4.1 Overview
10.4.2 Home-Care: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
10.5 Others
10.5.1 Overview
10.5.2 Others: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
11. South & Central America Rapid Test Kits Market – Country Analysis
11.1 South & Central America
11.1.1 Overview
11.1.2 South & Central America: Rapid Test Kits Market – Revenue and Forecast Analysis – by Country
11.1.2.1 Brazil
11.1.2.1.1 Overview
11.1.2.2 Brazil: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
11.1.2.2.1 Brazil: Rapid Test Kits Market Breakdown, by Type
11.1.2.2.2 Brazil: Rapid Test Kits Market Breakdown, by Product
11.1.2.2.3 Brazil: Rapid Test Kits Market Breakdown, by Technology
11.1.2.2.4 Brazil: Rapid Test Kits Market Breakdown, by Application
11.1.2.2.4.1 Brazil: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
11.1.2.2.5 Brazil: Rapid Test Kits Market Breakdown, by End User
11.1.2.3 Argentina
11.1.2.3.1 Overview
11.1.2.4 Argentina: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
11.1.2.4.1 Argentina: Rapid Test Kits Market Breakdown, by Type
11.1.2.4.2 Argentina: Rapid Test Kits Market Breakdown, by Product
11.1.2.4.3 Argentina: Rapid Test Kits Market Breakdown, by Technology
11.1.2.4.4 Argentina: Rapid Test Kits Market Breakdown, by Application
11.1.2.4.4.1 Argentina: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
11.1.2.4.5 Argentina: Rapid Test Kits Market Breakdown, by End User
11.1.2.5 Rest of South & Central America
11.1.2.5.1 Overview
11.1.2.6 Rest of South & Central America: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
11.1.2.6.1 Rest of South & Central America: Rapid Test Kits Market Breakdown, by Type
11.1.2.6.2 Rest of South & Central America: Rapid Test Kits Market Breakdown, by Product
11.1.2.6.3 Rest of South & Central America: Rapid Test Kits Market Breakdown, by Technology
11.1.2.6.4 Rest of South & Central America: Rapid Test Kits Market Breakdown, by Application
11.1.2.6.4.1 Rest of South & Central America: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
11.1.2.6.5 Rest of South & Central America: Rapid Test Kits Market Breakdown, by End User
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Rapid Test Kit Market
12.3 Inorganic Growth Strategies
12.3.1 Overview
12.4 Organic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 F. Hoffmann-La Roche Ltd
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Becton Dickinson and Co
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 ARKRAY Inc
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Fujirebio Europe NV
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 bioMerieux SA
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Cepheid
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Meril Life Sciences Pvt Ltd
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 QIAGEN NV
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Guangzhou Wondfo Biotech Co Ltd
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Abbott Laboratories
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 Trinity Biotech Plc
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
13.12 Bio-Rad Laboratories Inc
13.12.1 Key Facts
13.12.2 Business Description
13.12.3 Products and Services
13.12.4 Financial Overview
13.12.5 SWOT Analysis
13.12.6 Key Developments
13.13 Hologic Inc
13.13.1 Key Facts
13.13.2 Business Description
13.13.3 Products and Services
13.13.4 Financial Overview
13.13.5 SWOT Analysis
13.13.6 Key Developments
13.14 DiaSorin SpA
13.14.1 Key Facts
13.14.2 Business Description
13.14.3 Products and Services
13.14.4 Financial Overview
13.14.5 SWOT Analysis
13.14.6 Key Developments
13.15 Premier Medical Corp Pvt Ltd
13.15.1 Key Facts
13.15.2 Business Description
13.15.3 Products and Services
13.15.4 Financial Overview
13.15.5 SWOT Analysis
13.15.6 Key Developments
13.16 Beckman Coulter Inc
13.16.1 Key Facts
13.16.2 Business Description
13.16.3 Products and Services
13.16.4 Financial Overview
13.16.5 SWOT Analysis
13.16.6 Key Developments
14. Appendix
14.1 About The the Reporting Teams

LIST OF TABLES

Table 1. Rapid Test Kits Market Segmentation
Table 2. Infectious Disease Testing: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
Table 3. Brazil: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 4. Brazil: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 5. Brazil: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by Technology
Table 6. Brazil: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 7. Brazil: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by Infectious Disease Testing
Table 8. Brazil: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 9. Argentina: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 10. Argentina: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 11. Argentina: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by Technology
Table 12. Argentina: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 13. Argentina: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by Infectious Disease Testing
Table 14. Argentina: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 15. Rest of South & Central America: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 16. Rest of South & Central America: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 17. Rest of South & Central America: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by Technology
Table 18. Rest of South & Central America: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 19. Rest of South & Central America: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by Infectious Disease Testing
Table 20. Rest of South & Central America: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 21. Recent Inorganic Growth Strategies in the Rapid Test Kit Market
Table 22. Recent Organic Growth Strategies in the Rapid Test Kit Market

LIST OF FIGURES

Figure 1. Rapid Test Kits Market Segmentation, By Country
Figure 2. Rapid Test Kits Market: Key Industry Dynamics
Figure 3. Rapid Test Kits Market: Impact Analysis of Drivers and Restraints
Figure 4. Rapid Test Kits Market Revenue (US$ Mn), 2020 – 2030
Figure 5. Rapid Test Kits Market Share (%) – by Type (2022 and 2030)
Figure 6. Rapid Antigen Testing: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Rapid Antibody Testing: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Others: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Rapid Test Kits Market Share (%) – by Product (2022 and 2030)
Figure 10. Over-the-Counter Rapid Testing Kit: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Professional Rapid Testing Kit: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Rapid Test Kits Market Share (%) – by Technology (2022 and 2030)
Figure 13. Lateral Flow Assay: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Solid Phase: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Agglutination: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Immunospot Assay: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Cellular-Component Based: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Rapid Test Kits Market Share (%) – by Application (2022 and 2030)
Figure 19. Blood Glucose Testing: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Infectious Disease Testing: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Cardiometabolic Testing: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Pregnancy and Fertility: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Others: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. Rapid Test Kits Market Share (%) – by End User (2022 and 2030)
Figure 25. Hospital and Clinics: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
Figure 26. Diagnostic Centers: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. Home-Care: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
Figure 28. Others: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
Figure 29. South & Central America: Parenteral Nutrition Market, By Key Country – Revenue (2022) (US$ Million)
Figure 30. South & Central America: Rapid Test Kits Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 31. Brazil: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million)
Figure 32. Argentina: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million)
Figure 33. Rest of South & Central America: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million)
Figure 34. Growth Strategies in the Rapid Test Kit Market

The List of Companies – South & Central America Rapid Test Kit Market

1. F. Hoffmann-La Roche Ltd
2. Becton Dickinson and Co
3. ARKRAY Inc
4. Fujirebio Europe NV
5. bioMerieux SA
6. Cepheid
7. Meril Life Sciences Pvt Ltd
8. QIAGEN NV
9. Guangzhou Wondfo Biotech Co Ltd
10. Abbott Laboratories
11. Trinity Biotech Plc
12. Bio-Rad Laboratories Inc
13. Hologic Inc
14. Premier Medical Corp Pvt Ltd
15. DiaSorin SpA
16. Beckman Coulter Inc

Reviews

There are no reviews yet.

Be the first to review “South & Central America Rapid Test Kit Market Forecast to 2030”